487 related articles for article (PubMed ID: 23486238)
1. The effects of PEDF on cancer biology: mechanisms of action and therapeutic potential.
Becerra SP; Notario V
Nat Rev Cancer; 2013 Apr; 13(4):258-71. PubMed ID: 23486238
[TBL] [Abstract][Full Text] [Related]
2. Characterization of PEDF: a multi-functional serpin family protein.
Filleur S; Nelius T; de Riese W; Kennedy RC
J Cell Biochem; 2009 Apr; 106(5):769-75. PubMed ID: 19180572
[TBL] [Abstract][Full Text] [Related]
3. The role of PEDF in tumor growth and metastasis.
Hoshina D; Abe R; Yamagishi SI; Shimizu H
Curr Mol Med; 2010 Apr; 10(3):292-5. PubMed ID: 20236054
[TBL] [Abstract][Full Text] [Related]
4. PEDF and its roles in physiological and pathological conditions: implication in diabetic and hypoxia-induced angiogenic diseases.
He X; Cheng R; Benyajati S; Ma JX
Clin Sci (Lond); 2015 Jun; 128(11):805-23. PubMed ID: 25881671
[TBL] [Abstract][Full Text] [Related]
5. PEDF: a potential molecular therapeutic target with multiple anti-cancer activities.
Ek ET; Dass CR; Choong PF
Trends Mol Med; 2006 Oct; 12(10):497-502. PubMed ID: 16962374
[TBL] [Abstract][Full Text] [Related]
6. Anti-tumor effects of pigment epithelium-derived factor (PEDF): implication for cancer therapy. A mini-review.
Belkacemi L; Zhang SX
J Exp Clin Cancer Res; 2016 Jan; 35():4. PubMed ID: 26746675
[TBL] [Abstract][Full Text] [Related]
7. Neuroprotective and antiangiogenic actions of PEDF in the eye: molecular targets and therapeutic potential.
Barnstable CJ; Tombran-Tink J
Prog Retin Eye Res; 2004 Sep; 23(5):561-77. PubMed ID: 15302351
[TBL] [Abstract][Full Text] [Related]
8. Focus on Molecules: Pigment epithelium-derived factor (PEDF).
Becerra SP
Exp Eye Res; 2006 May; 82(5):739-40. PubMed ID: 16364294
[No Abstract] [Full Text] [Related]
9. Pigment epithelium-derived factor in lipid metabolic disorders.
Huang KT; Lin CC; Tsai MC; Chen KD; Chiu KW
Biomed J; 2018 Apr; 41(2):102-108. PubMed ID: 29866598
[TBL] [Abstract][Full Text] [Related]
10. The many facets of PEDF in drug discovery and disease: a diamond in the rough or split personality disorder?
Craword SE; Fitchev P; Veliceasa D; Volpert OV
Expert Opin Drug Discov; 2013 Jul; 8(7):769-92. PubMed ID: 23642051
[TBL] [Abstract][Full Text] [Related]
11. Pathophysiological role of pigment epithelium-derived factor (PEDF) in hepatic disorders.
Yamagishi SI; Matsui T; Kawaguchi T; Sata M
Curr Med Chem; 2010; 17(19):1995-2000. PubMed ID: 20423314
[TBL] [Abstract][Full Text] [Related]
12. The pathophysiological role of PEDF in bone diseases.
Broadhead ML; Akiyama T; Choong PF; Dass CR
Curr Mol Med; 2010 Apr; 10(3):296-301. PubMed ID: 20236053
[TBL] [Abstract][Full Text] [Related]
13. Involvement of the collagen I-binding motif in the anti-angiogenic activity of pigment epithelium-derived factor.
Hosomichi J; Yasui N; Koide T; Soma K; Morita I
Biochem Biophys Res Commun; 2005 Sep; 335(3):756-61. PubMed ID: 16102727
[TBL] [Abstract][Full Text] [Related]
14. Effects of pigment epithelium-derived factor on traumatic brain injury.
Terzi MY; Casalis P; Lang V; Zille M; Bründl E; Störr EM; Brawanski A; Vajkoczy P; Thomale U; Piña AL
Restor Neurol Neurosci; 2015; 33(1):81-93. PubMed ID: 25420903
[TBL] [Abstract][Full Text] [Related]
15. The applied biochemistry of PEDF and implications for tissue homeostasis.
Broadhead ML; Becerra SP; Choong PF; Dass CR
Growth Factors; 2010 Aug; 28(4):280-5. PubMed ID: 20166889
[TBL] [Abstract][Full Text] [Related]
16. Antiangiogenic and antifibrogenic activity of pigment epithelium-derived factor (PEDF) in bile duct-ligated portal hypertensive rats.
Mejias M; Coch L; Berzigotti A; Garcia-Pras E; Gallego J; Bosch J; Fernandez M
Gut; 2015 Apr; 64(4):657-66. PubMed ID: 24848263
[TBL] [Abstract][Full Text] [Related]
17. Therapeutic Potential of Pigment Epithelium-derived Factor in Cancer.
Yamagishi SI; Koga Y; Sotokawauchi A; Hashizume N; Fukahori S; Matsui T; Yagi M
Curr Pharm Des; 2019; 25(3):313-324. PubMed ID: 30892156
[TBL] [Abstract][Full Text] [Related]
18. Pigment epithelium-derived factor: a multimodal tumor inhibitor.
Ek ET; Dass CR; Choong PF
Mol Cancer Ther; 2006 Jul; 5(7):1641-6. PubMed ID: 16891449
[TBL] [Abstract][Full Text] [Related]
19. Pigment epithelium-derived factor: a key mediator in bone homeostasis and potential for bone regenerative therapy.
Baxter-Holland M; Dass CR
J Pharm Pharmacol; 2018 Sep; 70(9):1127-1138. PubMed ID: 29978595
[TBL] [Abstract][Full Text] [Related]
20. Current Evidence and Potential Mechanisms of Therapeutic Action of PEDF in Cervical Cancer Treatment.
Han J; Guo J
Curr Mol Med; 2015; 15(5):446-55. PubMed ID: 26122658
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
